Vermillion Debt to Equity Ratio 2006-2018 | VRML

Current and historical debt to equity ratio values for Vermillion (VRML) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Vermillion debt/equity for the three months ending September 30, 2018 was 0.14.
Vermillion Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.00B $0.01B 0.14
2018-06-30 $0.00B $0.01B 0.12
2018-03-31 $0.00B $0.00B 1.16
2017-12-31 $0.00B $0.00B 0.44
2017-09-30 $0.00B $0.01B 0.26
2017-06-30 $0.00B $0.01B 0.34
2017-03-31 $0.00B $0.01B 0.24
2016-12-31 $0.00B $0.00B 0.44
2016-09-30 $0.00B $0.01B 0.27
2016-06-30 $0.00B $0.01B 0.19
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.02B 0.00
2015-09-30 $0.00B $0.02B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.02B 0.00
2014-12-31 $0.00B $0.02B 0.00
2014-09-30 $0.00B $0.01B 0.00
2014-06-30 $0.00B $0.02B 0.00
2014-03-31 $0.00B $0.02B 0.00
2013-12-31 $0.00B $0.03B 0.00
2013-09-30 $0.00B $0.01B 0.00
2013-06-30 $0.00B $0.01B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.01B 0.00
2012-09-30 $0.00B $0.01B 0.00
2012-06-30 $0.00B $0.01B 0.00
2012-03-31 $0.00B $0.01B 0.00
2011-12-31 $0.00B $0.01B 0.00
2011-09-30 $0.01B $0.01B 0.53
2011-06-30 $0.01B $0.02B 0.40
2011-03-31 $0.01B $0.02B 0.32
2010-12-31 $0.01B $0.01B 1.52
2010-09-30 $0.01B $0.00B 1.56
2010-06-30 $0.00B $0.00B 0.00
2010-03-31 $0.00B $0.00B 0.00
2009-12-31 $0.01B $-0.03B -0.37
2009-09-30 $0.00B $0.00B 0.00
2009-06-30 $0.00B $0.00B 0.00
2009-03-31 $0.00B $0.00B 0.00
2008-12-31 $0.00B $0.00B 0.00
2008-09-30 $0.03B $-0.03B -1.06
2008-06-30 $0.03B $-0.02B -1.28
2008-03-31 $0.03B $-0.02B -1.59
2007-12-31 $0.03B $-0.01B -2.29
2007-09-30 $0.03B $-0.01B -3.23
2007-06-30 $0.03B $-0.02B -1.28
2007-03-31 $0.03B $-0.02B -1.73
2006-12-31 $0.03B $-0.01B -2.57
2006-09-30 $0.04B $-0.01B -2.91
2006-06-30 $0.03B $-0.01B -6.12
2006-03-31 $0.03B $0.00B 20.96
2005-12-31 $0.03B $0.01B 4.77
2005-09-30 $0.03B $0.02B 1.89
2005-06-30 $0.03B $0.01B 3.31
2005-03-31 $0.03B $0.02B 1.63
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.035B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.279B 21.97
Intuitive Surgical (ISRG) United States $56.165B 55.26
Edwards Lifesciences (EW) United States $33.475B 35.82
Fresenius Medical Care AG KGaA (FMS) Germany $20.859B 14.10
IDEXX Laboratories (IDXX) United States $16.408B 46.87
ABIOMED (ABMD) United States $14.241B 102.33
Hologic (HOLX) United States $12.130B 18.72
Teleflex (TFX) United States $11.377B 25.83
Varian Medical Systems (VAR) United States $10.852B 27.01
DexCom (DXCM) United States $10.720B 0.00
STERIS (STE) United Kingdom $9.561B 25.37
Masimo (MASI) United States $5.673B 36.78
LivaNova (LIVN) United Kingdom $4.598B 29.52
Globus Medical (GMED) United States $4.389B 27.51
Penumbra (PEN) United States $4.327B 261.25
Integra LifeSciences Holdings (IART) United States $4.122B 20.08
Wright Medical Group (WMGI) Netherlands $3.442B 0.00
Cantel Medical (CMD) United States $3.310B 32.65
Inogen (INGN) United States $2.792B 60.27
Integer Holdings (ITGR) United States $2.729B 22.84
Halyard Health (AVNS) United States $2.274B 20.49
Glaukos (GKOS) United States $2.255B 0.00
Tandem Diabetes Care (TNDM) United States $2.028B 0.00
OPKO Health (OPK) United States $1.842B 0.00
Mazor Robotics (MZOR) Israel $1.535B 0.00
Nevro (NVRO) United States $1.192B 0.00
Luminex (LMNX) United States $1.138B 41.16
Pacific Biosciences Of California (PACB) United States $1.112B 0.00
AxoGen (AXGN) United States $1.096B 0.00
Natus Medical (BABY) United States $1.082B 22.71
CryoLife (CRY) United States $1.057B 92.19
Orthofix (OFIX) United States $1.039B 30.00
Intersect ENT (XENT) United States $0.935B 0.00
Tactile Systems Technology (TCMD) United States $0.932B 148.44
Mesa Laboratories (MLAB) United States $0.799B 47.23
AngioDynamics (ANGO) United States $0.779B 27.26
Accelerate Diagnostics (AXDX) United States $0.699B 0.00
ViewRay (VRAY) United States $0.602B 0.00
Veracyte (VCYT) United States $0.495B 0.00
SI-BONE INC (SIBN) United States $0.491B 0.00
Sientra (SIEN) United States $0.441B 0.00
OrthoPediatrics (KIDS) United States $0.422B 0.00
Quotient (QTNT) Switzerland $0.391B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.367B 0.00
Neuronetics (STIM) United States $0.353B 0.00
Accuray (ARAY) United States $0.328B 0.00
SeaSpine Holdings (SPNE) United States $0.307B 0.00
Fluidigm (FLDM) United States $0.306B 0.00
IRadimed (IRMD) United States $0.295B 77.20
Nuvectra (NVTR) United States $0.293B 0.00
RTI Surgical (RTIX) United States $0.263B 41.50
GenMark Diagnostics (GNMK) United States $0.256B 0.00
Helius Medical Technologies (HSDT) United States $0.253B 0.00
Pulse Biosciences (PLSE) United States $0.203B 0.00
T2 Biosystems (TTOO) United States $0.173B 0.00
Alphatec Holdings (ATEC) United States $0.108B 0.00
Ekso Bionics Holdings (EKSO) United States $0.103B 0.00
Ra Medical Systems (RMED) United States $0.099B 0.00
Sensus Healthcare (SRTS) United States $0.092B 0.00
Apollo Endosurgery (APEN) United States $0.088B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.085B 0.00
Second Sight Medical Products (EYES) United States $0.067B 0.00
Biosig Technologies (BSGM) United States $0.065B 0.00
EDAP TMS (EDAP) France $0.064B 0.00
Viveve Medical (VIVE) United States $0.042B 0.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Restoration Robotics (HAIR) United States $0.038B 0.00
ConforMIS (CFMS) United States $0.033B 0.00
PAVmed (PAVM) United States $0.028B 0.00
Lianluo Smart (LLIT) China $0.027B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Titan Medical (TMDI) Canada $0.021B 0.00
DarioHealth (DRIO) Israel $0.019B 0.00
Neovasc (NVCN) Canada $0.015B 0.00
Bioanalytical Systems (BASI) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.011B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.006B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00